|Assessment Status||Rapid Review complete|
|Indication||As adjunctive therapy in the treatment of partial-onset seizures (POS) with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.|
|Rapid review commissioned||15/02/2016|
|Rapid review completed||22/03/2016|
|Rapid review outcome||Full Pharmacoeconomic Evaluation Recommended at the submitted price.|
The HSE has approved reimbursement following confidential price negotiations.